Jesus Daily: 365 Interactive Devotions

Name: Jesus Daily: 365 Interactive Devotions
Brand: FaithWords
SKU: 577232
Price: 9.74 USD
Availability: InStock
Rating: 5 (2 reviews)
Author: Aaron M.D. Tabor
ISBN: 9781455577231

By: Aaron M.D. Tabor

FaithWords / 2014 / Hardcover

5 out of 5 stars for Jesus Daily: 365 Interactive Devotions Write a Review

In Stock

Stock No: WW577232

Buy Item $9.74 Retail: ~~$17.00~~ Save 43% ($7.26)

5 out of 5 stars for Jesus Daily: 365 Interactive Devotions

In Stock

Quantity:

Stock No: WW577232

FaithWords / 2014 / Hardcover

Quantity:

Add To Cart

or checkout with

Product Close-up

Product Description

▼▲

Based on major themes found on the most active Facebook page in history, this 365-day devotional goes beyond fan frenzy to create a deeper experience and cultural movement that celebrates your redemption in Christ. Each day you'll be challenged to respond to an inspirational reflection by using a variety of social media tools. 400 pages, hardcover from Faithwords.

Product Information

▼▲

Title: Jesus Daily: 365 Interactive Devotions
By: Aaron M.D. Tabor
Format: Hardcover
Number of Pages: 400
Vendor: FaithWords
Publication Date: 2014

Dimensions: 6 X 4 (inches)
Weight: 1 pound 1 ounce
ISBN: 1455577235
ISBN-13: 9781455577231
Stock No: WW577232

Publisher's Description

▼▲

Based on the major themes found on the most active Facebook page in history, Jesus Daily is a 365-day interactive devotional that goes beyond even the fan page to create a deeper experience and cultural movement that celebrates your redemption in Christ. Jesus Daily presents a devotional thought but also challenges you to respond to each daily reflection using a variety of social media tools.

Jesus Daily is a worldwide revolution in how you can connect, share, and worship the Father personally and with other believers.

Author Bio

▼▲

Aaron Tabor, MD, started the Jesus Daily Facebook page in 2009. He is the President of Gene Facelift, a gene therapy biotechnology company developing anti-aging and wound healing drugs. Dr. Tabor is a graduate of The Johns Hopkins School of Medicine.